Summit Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6M | 80k | 20.66 |
| 2025-06-30 | $1.8M | 87k | 21.28 |
| 2024-03-31 | $474k | 115k | 4.14 |
| 2023-12-31 | $151k | 58k | 2.61 |
| 2023-09-30 | $108k | 58k | 1.87 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas